COVID-19: The false promise of Hydroxychloroquine
A new study published in the Biomedicine & Pharmacotherapy journal estimates that the use of hydroxychloroquine to treat COVID-19 was associated with nearly 17,000 deaths in six countries during the first wave of the pandemic.
A new study published in the Biomedicine & Pharmacotherapy journal estimates that the use of hydroxychloroquine to treat COVID-19 was associated with nearly 17,000 deaths in six countries during the first wave of the pandemic.
I n the early days of the COVID-19 pandemic, hydroxychloroquine (HCQ) was hailed as a potential miracle cure. The drug, which is used to treat malaria and lupus, was shown to have antiviral properties in laboratory studies. However, subsequent clinical trials found that hydroxychloroquine was not effective in treating COVID-19 and may actually be harmful.
The Study
The new study by researchers at the University Hospital of Lyon analysed data from six countries: France, the United States, Belgium, Italy, Spain, and Turkey. The researchers found that patients treated with hydroxychloroquine had an 11% higher risk of death than those who were not treated with the drug.
“Hydroxychloroquine was prescribed in hospitalised patients with COVID-19 despite of the low-level evidence.
“Subsequently, HCQ use was associated with an 11% increase in the mortality rate in a meta-analysis of randomized trials.”
— Study
CONTINUE READING...
Enjoy unlimited access now.
To get full access to this article,
simply become a member of EUROPEANS TODAY now.
By doing so, you will be supporting
our independent journalism.
MEMBERSHIP OPTIONS:
£3/month ∙ £5/month ∙ £7/month
You can cancel anytime.
BECOME A MEMBER
Already a member? Sign in here!
BENEFITS OF MEMBERSHIP:
✅ Read exclusive member-only articles
✅ Read our daily review of the UK front pages
✅ Receive every new article by email
✅ Access all our articles
✅ Get Special Discounts with our partners
✅ Join the conversation: Comment our articles
✅ Access our archives
✅ More importantly: Support independent journalism and keep the magazine going
Read more
— Since 2018, over 170,000 people have crossed the Channel to claim asylum in the UK, yet limited safe and legal routes force many into perilous journeys, campaigners warn.
— Stay ahead of the curve with your daily briefing on the must-read headlines from across Europe. From the UK to France, Germany, Italy, Spain, and beyond — this is your essential guide to the front pages shaping the conversation today.
— Mounting economic woes, debt risks and pension pressures mean UK Chancellor Rachel Reeves faces tough choices: risk tax hikes or spending cuts that threaten growth, or gamble on investment-driven recovery.
— AI-driven tools like Plan AI can swiftly summarise vast public feedback on planning, easing administrative burdens for UK authorities and potentially making urban planning more efficient, democratic, and transparent.
|
|
